Applying artificial intelligence (AI) to patient profiles reveals which ones could benefit most from Salonpas.
Study points to novel and precise approach for healthcare practitioners to best select topical pain treatments.
In light of the potential adverse effects associated with many classes of analgesics, Hisamitsu America continues to push into new, beneficial areas of study as it relates to our belief in delivering “Good Medicine” to people in pain. Recently, KOLs and other researchers at InSyBio Ltd, applied artificial intelligence and predictive analytic modeling to data from the RELIEF clinical study. The study used a new method to identify patient profiles who are predicted to benefit most from Salonpas Pain Relieving Patch. An ability to predict ‘response to treatment’ could prove tremendously beneficial to healthcare professionals and their patients.